Influence of enhancers on the absorption and on the pharmacokinetics of cefodizime using in-vitro and in-vivo models

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 4, 2004, Pages 485-493

  Mrestani, Yahya ^a   Bretschneider, Beate ^a   Härtl, Albert ^b   Brandsch, Matthias ^a   Neubert, Reinhard H H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b HANS KNÖLL INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZALKONIUM CHLORIDE; BUFFER; CATION; CEFODIZIME; CEPHALOSPORIN DERIVATIVE; CETRIMIDE; DODECYLTRIMETHYLAMMONIUM BROMIDE; GLUCOSE; OCTANOL; PENETRATION ENHANCING AGENT; PYRIDINIUM DERIVATIVE; WATER;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; BIOLOGICAL MODEL; CELL MEMBRANE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG RESEARCH; DRUG SOLUBILITY; DRUG TRANSPORT; EXCIPIENT COMPATIBILITY; FEMALE; GLUCOSE TRANSPORT SYSTEM; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INJECTION; LIPOPHILICITY; NONHUMAN; PARTITION COEFFICIENT; PHYSIOLOGY; RABBIT;

1-OCTANOL; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; BUFFERS; CACO-2 CELLS; CEFOTAXIME; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GUINEA PIGS; HUMANS; INTESTINAL ABSORPTION; MEMBRANES, ARTIFICIAL; PERMEABILITY; RABBITS; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 1842523977     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357023187     Document Type: Article

References (37)

1. Abe, S., Inazu, M., Yajima, R., Morioka, H., Kobayashi, T. (1988) One-month subacute intravenous toxicity study of cefodizime sodium in rats. J. Toxicol. Sci. 13: 21-42
2. Auterhoff, H., Knabe, J., Höltje, H. D. (1991) Lehrbuch der pharmazeutischen Chemie. Vol. 12, Wiss. Verl., Stuttgart, pp 51-58
3. Bakk, P., Phillips, I. (1990) A parenteral cephalosporin: pharmacokinetic profile. Hoechst, pp 31-40
4. +/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm. Res. 16: 55-61
5. Brockmeier, D., Dagrosa, E. E. (1992) Pharmacokinetic profile of cefodizime. Infection 20 (Suppl. 1): S14-S17
6. +-activated D-glucose transport systems in guinea pig jejunal brush border membrane. J. Biol. Chem. 261: 6168-6176
7. Bryskier, A., Procyk, T., Tremblay, D., Lenfant, B., Fourtillan, J. B. (1990) The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 g. Antimicrob. Chemother. 26 (Suppl. C): 59-63
8. Collins, A. E., Deasy, P. (1990) Bioadhesive lozenge for the improved delivery of cetylpyridinium chloride. J. Pharm. Sci. 79: 116-120
9. Doerffel, K., Geyer, R., Müller, H. (1994) Analytikum. Deutscher Verlag für Grundstoffindustrie, Leipzig, Stuttgart
10. Durckheimer, W., Adam, F., Fischer, G., Kirrstetter R. (1988) Recent developments in the field of cephem antibiotics. In: Testa, B. (ed.) Advances in drug research. Academic Press, New York, pp 61-233
11. Eugenie, B. B. (1996) Oral cephalosporins in the treatment of respiratory tract infections. Curr. Ther. Res. 57: 87-89
12. Grass, G. M., Sweetana, S. A. (1998) In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell. Pharm. Res. 5: 372-376
13. Heinzel, G., Woloszcak, R., Thomann, P. (1993) TOPFIT 2.0 Pharmacokinetic and pharmacodynamic data analysis for the PC. Gustav Fischer Verlag, Stuttgart, Jena, New York
14. Isert, D., Klesel, N., Limbert, M., Markus, A., Seibert, G., Schrinner, E. (1992) Pharmacokinetics of cefpirom administered intravenously or intramuscularly to rats and dogs. J. Antimicrob. Chemother. 29: 31-37
15. Kakemi, K., Sezaki, H., Muranishi, S., Tsujimura, Y. (1969) Absorption and excretion of drug. XL. Enhancement of the rectal absorption of pharmaceutical amines with lauryl sulfate and saccharinate anions. Chem. Pharm. Bull. 17: 1641-1650
16. Kavi, J., Andrews, J. M., Ashby, J. P., Hillman, G., Wise, R. (1988) Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin. J. Antimicrob. Chemother. 22: 911-916
17. King, J. H., Cohen, S. H. (1995) Focus on ceftibuten: A third-generation oral cephalosporin antibiotic. Hosp. Formul. 30: 85-91
18. Lee, C. P., De Vrueh, R. L. A., Smith, P. L. (1996) Transport of a prodrug of acyclovir, L-Val-acyclovir, via the oligopeptide transporter. Proc. Int. Symp. Controlled Release Bioact. Mater. 23: 47-48
19. Malchiodi-Albedi, F., Ciaralli, F., Guiliani, A. (1991) Increased osmiophilia of glycosaminoglycan like structures after fixation with cetylpyridinium chloride in human colonic mucosa. J. Submicrosc. Cytol. Pathol. 23: 415-418
20. Mrestani, Y., Neubert, R., Schiewe, J., Härtl, A. (1996) Application of capillary zone electrophoresis in cephalosporin analysis. J. Chromatogr. B 690: 321-326
21. Mrestani, Y., Neubert, R., Härtl A., Wohlrab, J. (1997) Determination of cephalosporins in urine and bile by capillary zone electrophoresis. Anal. Chim. Acta 349: 207-213
22. Mrestani, Y., Neubert, R., Munk, A., Wiese M. (1998) Determination of dissociation constants of cephalosporins by capillary electrophoresis. J. Chromatogr. A 803: 273-278
23. Neubert, R., Fürst, W. (1989) In vitro-Untersuchungen des Arzneistofftransports. Pharm. Unserer Zeit 18: 112-124
24. Nishihata, B. T., Lee, C. S., Rytting, J. H., Higuchi, T. (1987) The synergistic effects of concurrent administration to rats of EDTA and sodium salicylate on the rectal absorption of sodium cefoxitin and the effect of inhibitors. J. Pharm. Pharmacol. 39: 180-184
25. Palin, K. J., Phillips, A. J., Ning, A. (1986) The oral absorption of cefoxitin from oil emulsion vehicles in rats. Int. J. Pharm. 33: 99-104
26. Park, G. E., Jeon, S., Lee, K. P. (1995) Effect of ion-pair on jejunal and nasal absorption of cefotaxim. Yakche Hakhoechi 25: 353-363
27. Saitoh, H., Noujoh, A., Chiba, Y., Iseki, K., Arita, T. (1990) Correlation between structure of organic cations and their binding behaviours to brush border membrane isolated from rat small intestine. J. Pharmacol. 42: 308-313
28. Sancho, C. V., Fabra, C. S., Gomez, M. V., Bengochea, M., Martin, V. A. (1995) Experimental studies on the influence of surfactants on intestinal absorption of drugs. Drug Res. 45: 595-601
29. Smith, P. L., Wall, D. A., Gochoco, C. H., Wilson, G. (1992) Case studies. Oral absorption of peptides and proteins. Drug Deliv. 8: 253-290
30. Smith, P. L., Eddy, E. P., Lee, C. P., Wilson, G. (1996) Exploitation of the intestinal oligopeptide transporter to enhance drug absorption. Drug Deliv. 3: 117-123
31. Tacnet, F., Lauthier, F., Ripoche, P. (1993) Mechanisms of zinc transport into pig small intestine brush-border membrane vesicles. J. Physiol. 465: 57-72
32. Tsuji, A., Miyamoto, E., Matsuda, M., Nishimura, K., Yamana, T. (1982) Effects of surfactants on the aqueous stability and solubility of beta-lactam antibiotics. J. Pharm. Sci. 71: 1313-1318
33. Van Hoogdalem, E. J., De Boer, A. G., Breimer, D. D. (1989) Intestinal drug absorption enhancement: An overview. Pharmacol. Ther. 44: 407-443
34. Van Krimpen, P. C., Van Bennekom, W. P., Bult, A. (1987) Penicillins and cephalosporins. Physicochemical properties and analysis in pharmaceutical and biological matrices. Pharm. Weekbl. Sci. 9: 1-23
35. Wagner, C. (1996) Das Transportverhalten topisch applizierter Antiseptika in künstlichen und biologischen Membransystemen. Doctoral Thesis, Martin-Luther-University Halle-Wittenberg, Halle
36. Wise, R., Andrews, J. M., Ashby, J. P. (1990) In-vitro activity of cefodizime against respiratory pathogens. J. Antimicrob. Chemother. 26: 9-12
37. Yamamoto, H., Terasawa, T., Ohki, A., Shirai, F., Kawabata, K.. (2000) Orally active cephalosporins: Synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporin. Bioorg. Med. Chem. 8: 43-54